Javier Pinilla, MD, PhD explores evidence on molecular mechanisms leading to resistance in second-generation BTK inhibitors for CLL, providing insights from recently presented data at ASH 2023.
Bipolar and ADHD treatment is complicated and nuanced, in part because stimulant use carries possible risks for bipolar patients. Here, understand the research on using methylphenidate and mixed amphetamine salts.
Differential diagnosis of bipolar disorder and ADHD is complicated by high rates of comorbidity and overlapping symptoms. Medical history can help distinguish the conditions.